Product Profiles

Article

A round-up of the latest ophthalmic products

Preloaded IOL Platform

The MicroShooter uses MiniIN technology, which means constant incision sizes independent of implantation technique and insertion depth are guaranteed. The platform is already loaded with products from the aspheric Aspira-Family.

Intraoperative tamponades

The perfluorocarbon liquids (PFCLS) do not need to be poured from a vial into a syringe. The flange of the syringe is ergonomically formed, meaning the injections of PFCLS are safer and easier.

For more information please visit: http://www.geuder.com/

Tonosafe disposable prisms

The Tonosafe disposable prisms, developed by HaagStreit, reduce the risk of cross-infection between patients and contact tonometry.

Tonosafe is now available globally and promises accurate results when used in conjunction with the Goldmann Applanation Tonometer and the Perkins Tonometer.

For further information please visit: http://www.haag-streit.com/

Non-mydriatic fundus camera

CSO's imaging optical system, Cobra, provides digital fundus imaging of high resolution and fine gradation.

Cobra shares the use of a 2 Megapixel CCD camera for alignment with IR illumination and capture with White light flash and is able to work with a minimum 2.5 mm pupil diameter. The Cobra system has a Mosaic function and an infrared picture to display the subretinal layer.

For further details please visit: http://www.csoitalia.it

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.